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Abstract
Background: Histories of kidney transplantation rarely mention a series reported by Gordon Murray of Toronto and published by the
American Journal of Surgery 50 years ago.
Methods: The papers and biographies of Gordon Murray were reviewed in the context of knowledge at that time about renal failure
management to determine their contribution to transplantation research and to current practice.
Results: Murray proceeded from a unique leadership position in vascular surgery, anticoagulation therapy, and dialysis to undertake a
rational series of animal experiments and human trials of kidney transplantation that led him to the practices of graft irrigation, cold storage,
pelvic graft placement, renal-to-iliac vascular anastomoses, and ureterovesical anastomosis that continue to be used today. His animal
studies included the first attempts to use immunosuppression and total body irradiation to prevent rejection. His observation that rejection
may result in graft thrombosis and his attempts to prevent it with heparin anticipated current efforts to use newer agents for the same purpose
in sensitized allotransplantation and xenotransplantation.
Conclusions: Modern renal transplantation is founded on many of the principles expounded by Gordon Murray 50 years ago. © 2005
Excerpta Medica Inc. All rights reserved.
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In May 1954, the American Journal of Surgery published
the first series of clinical kidney transplantation [1]. Although provenance is as important in transplantation as in
any other area of surgery, this article is rarely cited and its
primary author, Gordon Murray, is not considered to be a
pioneer of kidney transplantation [2]. It is believed that he
was a technically gifted operator who turned his hand to
many diverse areas of surgery but that he had insufficient
knowledge of transplantation immunology to be so considered [3]. In December 1954, the Toronto report was overshadowed by news from Boston of successful kidney transplantation between identical twins [4]. Even though this
operation sidestepped the immunologic issues of transplantation, it is now considered the beginning of modern kidney
transplantation on the basis of progressive extension of the
technique to more disparate pairs [5]. Gordon Murray, probably in an effort to subsidize his privately funded research
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facility, moved to cancer research [6] and, ultimately, to
experiments in spinal cord regeneration [7]. His eclipse was
completed by accusations of fraudulent surgery arising out
of premature claims of successful spinal cord repair, which
resulted in his retirement at the age of 75 [3].
Early Years
Gordon Murray grew up on a farm in western Ontario,
where improvisation and “making do” were a way of life.
After graduation from the University of Toronto in 1921, he
apprenticed with a country surgeon, Dr Lorne Robertson, in
the small Ontario town of Stratford. Again improvisation
was frequently required [8]. This was the time of the frenzy
in Toronto regarding the discovery of insulin. The atmosphere of innovation and success imbued Murray with a
pioneering surgical spirit. After 18 months of country practice, he sought out formal surgical training in London, New
York, and Toronto. In 1927, he was appointed to staff in
Toronto where one of his duties was to lecture the students
on a very broad range of basic medical topics [3]. Almost
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immediately he began to develop new surgical treatments,
which included internal stenting of the malignant esophagus
(1931) and bone autotransplantation for scaphoid non-union
(1934) [3].
Charles Best, who had worked with Banting on the
discovery of insulin, sought him out to help with the development of heparin. A successful series of animal experiments and clinical trials established Murray as a leading
academic cardiovascular surgeon. He pioneered the treatment of deep vein thrombosis and pulmonary embolism,
arterial embolectomy, cardiac valve surgery, and interventicular septal defect repair. He was particularly adept at the
Blalock–Taussig repair and his practice established Toronto
as a center for surgical treatment of congenital heart disease.

Invention of a Dialysis Machine
Murray duplicated Alexis Carrel’s models to test heparin
in animals. In the 1930s he autotransplanted kidneys into the
neck of dogs [9]. At the time, he did not consider kidney
transplantation as a therapy but as a model of thrombosis.
Another model that he tested was the passage of blood
through tubes. Once he observed that heparin prevented
clotting, he realized an indefinite extracorporeal circulation
was possible. Casting around for “tissues, membranes or
substances [that] could be placed in circuit to remove poisonous substances” from the blood, he realized he might be
able to imitate the “action of a normal kidney” [10].
With a visiting trainee, Edmund Delorme of Edinburgh,
and a student chemist, Newell Thomas, Murray started
construction of “an artificial kidney” in 1945. The team
tested many natural and synthetic sheets before settling on
sausage casing made of cellulose as a membrane. They
quickly switched from tap water to Ringer’s solution for
dialysate and finally they devised an external pump to run a
veno-venous circuit because use of an arterial inflow was
found to be inefficient. In 1946, the first patient was dialyzed. The machine maintained a young woman who was
dying of acute renal failure as a consequence of a back street
abortion, until her own kidneys recovered. Murray presented the results of a series of patients to the Central
Surgical Association in Chicago in 1947 and papers were
published in various American and British journals over the
next few years [11].
Murray was unaware of the work of Willem Kolff, who
had designed a dialysis machine in 1943 in occupied
Holland. Both machines used a cellulose membrane, but
Kolff wound his tube around a cumbersome rotating drum
and employed the pressure of a femoral artery inflow to
power the circuit. It is interesting to note, in the light of
Murray’s transplantation legacy, that Kolff is today considered the inventor of dialysis even though it is Murray’s
designs that are currently used. In 1947, Kolff was invited to
the Brigham Hospital in Boston by George Thorn to present
Grand Rounds on his pioneering work in dialysis. Thorn,

who was chief of medicine, arranged for John Merrill and
Carl Walter to collaborate with Kolff in refining the machine, which became known as the Kolff–Brigham artificial
kidney [12].

Preclinical Transplant Research
Murray did not think it would ever be feasible to treat
chronic renal failure by dialysis. This was at a time when
chronic venous access was not available. He was, however,
uniquely placed to consider kidney transplantation, which
he felt offered to only hope of long-term survival without
native kidney function. Since the end of the Second World
War, Murray had become increasingly frustrated with the
failure of the Toronto General Hospital and the University
of Toronto to capitalize on his pioneering efforts in the way
American centers had supported their research successes.
He was concerned about younger rivals such a William
Bigelow and William Mustard who had returned from the
war as experienced surgeons. With the retirement of his
protector Dr William Gallie from the chair of surgery,
Murray felt threatened and he set up an independently
funded research institute outside of the university. The initial goal of the unit was to overcome the barriers to kidney
transplantation [3].
In 1946, Charles Hufnagel and David Hume at the
Brigham Hospital, at the suggestion of George Thorn, attached a kidney to the antecubital vessels of a woman dying
in circumstances identical to Murray’s first dialysis patient
[12]. The patient was revived with the temporary transplant,
which survived until spontaneous recovery of the native
kidneys occurred. Murray tried the same technique but was
dissatisfied with the renal function, which he put down to
insufficient blood flow from the arm [1]. He began a series of
animal experiments to isolate and overcome each problem.
Murray started with autotransplantation in dogs to determine the best technique for donor nephrectomy, optimum
storage conditions, and maximum storage time in order to
facilitate graft retrieval from a deceased donor. He determined that it was important to clamp the renal artery before
the vein in the donor to avoid parenchymal barotrauma. He
irrigated the kidneys with Ringer’s solution and he covered
them with a saline-soaked gauze. He was aware of
Bigelow’s experiments with hypothermia in cardiac surgery
and he discovered that cooling the kidneys down to between
10 and 4°C, using cooled perfusate and a bed of ice cubes,
increased the cold storage viability time from 2.5 hours at
room temperature to 5 hours. To determine long-term function he transplanted stored kidneys into nephrectomized
dogs using renal to iliac vessel anastomoses [1]. He was
able to achieve consistent long-term survival of stored kidneys autotransplanted in dogs and he performed a longitudinal study of the renal transplant pathology.
When he moved into a canine model of allotransplantation, Murray encountered difficulties most of which he
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attributed to vascular thrombosis. He added heparin to the
perfuasate without effect. He tried heparinization of the
animals. Many of the animals died of hemorrhage, but a few
survived up to 11 days. Murray decided the difference in
results between autotransplantation and allotransplantation
was an “immune reaction,” which he unsuccessfully tried to
counter first with pyribenzamine and then with total body
irradiation. Finally he tried desensitization by injecting increasing aliquots of mashed tissue from the opposite donor
kidney, a maneuver that not only failed to prevent but
appeared to accelerate thrombosis of the graft [1].

The First Modern Kidney Transplantation Series
In 1950, Richard Lawler of Chicago orthotopically transplanted a left kidney without immunosuppression into a
patient with renal insufficiency due to polycystic disease.
Excretion of dye from the left ureter was demonstrated at 52
days but all function was lost by 9 months [13]. This report,
described by those working in the field as a “bombshell”
[14], stimulated simultaneous but independent attempts at
clinical transplantation in Boston, Toronto, and Paris. David
Hume in Boston first tried to repeat the Lawler procedure
but abandoned it in favor of graft placement in the thigh
with a uretero-cutaneous fistula at the knee [12]. In Paris, 3
separate teams worked on kidney transplantation. Rene
Kuss placed the graft in the pelvic position. He anastomosed
the donor renal artery end-to-end to the hypogastric (internal iliac) artery but, like Hume, he used a cutaneous ureterostomy [14]. Murray had decided on the basis of his neck
autotransplantation experience of the 1930s to avoid external drainage of the ureter because of infection. He perfected
uretero-cycstostomy of a pelvic kidney transplant in the dog
and determined to use it in humans [1].
Starting in 1951, Murray performed a series of 4 deceased donor kidney transplants using his heterotopic technique [3]. The team included nurse Rita Smith, anesthetist
Stephen Evelyn, and resident William Lougheed. Both the
deceased donor and the prospective recipient were operated
on in the same room, Operating Room “C” at the Toronto
General Hospital, separated by a screen. Lougheed quickly
retrieved and cooled the graft with heparin and 8 L of
Ringer’s solution while Murray prepared a retroperitoneal
space in the recipient’s iliac fossa [1,10]. The graft was
brought to the recipient and the best location for transplantation
determined. End-to-side anastomoses between the donor renal
vessels and the recipient iliac vessels were made with 5.0
arterial silk suture applied in an interrupted everting fashion
first to the veins and then the arteries. The recipient was given
heparin intravenously before removal of the venous clamps,
which was followed by removal of the arterial clamps. The
kidney was seen to make urine during dissection of the bladder
and creation of the uretero-cystostomy [10].
All of the candidates were considered to be in the final
stages of chronic renal failure. Of the first 3 recipients, the
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longest survivor lived 12 days, even though urine excretion
and serum biochemical improvement were observed. On
May 2, 1952, Murray’s fourth patient was a 26-year-old
woman who had been diagnosed with Bright’s disease, 18
months previously. She had severe hypertension, 50 pounds
of edema, azotemia, and a urine-specific gravity of 1,005
[1]. Murray and Lougheed successfully performed the transplant in front of a large number of onlookers from the
hospital [10]. The patient made a spectacular recovery with
loss of all the edema and concentration of the urine to a
specific gravity of 1,020. Murray attempted to demonstrate
kidney function with an intravenous pyelogram. No function was seen in the native kidneys. Dye was seen in the
bladder, but the graft could not be seen against the wing of
the ilium [1]. The patient remained well for at least the next
21 years and the kidney was never removed [3]. In his report
to this journal, Murray admitted that while “this patient
might have returned to this sort of good health independently,” he remained convinced of the importance of the
transplant in achieving that state [1].

Conclusions
The Toronto kidney transplant series of 1951–52 was a
logically planned clinical research program that fit into the
continuum of not only its principal’s research and clinical
experience but also of transplantation research elsewhere in
the world at that time. Murray presented his findings to
several North American and International meetings. His
report was published months before the identical twin transplantation, in which the Boston team switched from the
Hume thigh technique to one similar to Murray’s. The
report of the Toronto series to this journal documented for
the first time many practices in kidney transplantation that
remain current today. These practices are not only clearly
outlined, but their origin in thought and experiment is also
documented. The experimental program may have been the
first to examine immunosuppression by chemotherapy or
irradiation even if the authors too readily gave up with
negative results.
Gordon Murray’s oft dismissal as a surgeon without
knowledge of immunobiology is not valid. His description
of thrombosis and necrosis with accelerated rejection is
accurate as are his histologic descriptions of less severe
rejection. Examining the long-term autotransplants that
failed, Murray noted “fibroplasia . . . . about the adventitia
of blood vessels,” which resulted in “the organ [being]
replaced practically completely by adult fibrous tissue with
full-sized degenerated parenchymal cells surrounded by [a]
lymphocytic infiltrate [that] was relatively slight” [1]. This
might be taken as the first description of what today is
termed chronic “transplant nephropathy.” In dealing with
allotransplantation, Murray discussed 3 forms of immune
reaction: “(1) a hypothetical cyctotoxic antibody; (2) a lympho[cy]tic infiltration; or (3) a replacement by fibrosis.”
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Finally, he discovered that prior immunization resulted in
an immune reaction that was more “rapid and extensive”
than that seen without immunization, which might be considered the first description of hyperacute rejection. One
could claim that Murray did not understand what he was
writing, but he did manage to describe the different forms of
rejection with uncanny accuracy before these forms were
known or named. The fact that he chose to intervene most
vigorously in the prevention of thrombosis is a reflection of
his own research success and not a dismissal by him of other
aspects of immunity. There are those today trying to overcome the barriers to sensitized allotransplantation or xenotransplantation who would find some appeal in Murray’s
belief that a vascularized organ transplant differed from skin
transplantation in that the encounter between recipient
blood and donor endothelium was the key to successful
transplantation.
Murray’s resident, Bill Lougheed, went to Boston in late
1954 to complete laboratory training. On his return to
Toronto he became a neurosurgeon and he applied his
experience to pioneer hypothermia and temporary circulatory arrest in aneurysm surgery. So why is Murray forgotten? The spectacular success of the Boston program not
only overshadowed his work, but its team approach contrasted sharply with Murray’s individualistic method. At the
time of his report to the American Journal of Surgery,
Murray had become alienated from his hospital and university authorities. He probably believed that support of his
corporate benefactors depended on newsworthy as opposed
to academic success. Ironically, in his switch to cancer
research, he attempted to raise anticancer antibodies in
horses using methods that would have given him antilymphocyte serum had he chosen to do so. Murray’s transplantation flaw was his prospect of success in other areas. His
papers are written in an imprecise pre-war narrative style.
The media’s insatiable appetite for instant success, coupled

with Murray’s increasing imprecision, resulted in his downfall at a time when he should have retired from a glorious
career. His last contribution to transplantation was to prove
experimentally that cardiac valves are not rejected in the
same way as organs and to perform, in 1955, the first heart
valve transplantation in a human [3].
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